Differential Regulation of $\beta $1 and $\beta $2 Integrin Avidity by Chemoattractants in Eosinophils
The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differenti...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 93; no. 20; pp. 10939 - 10944 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences of the United States of America
01.10.1996
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of $\beta $1 and $\beta $2 integrin avidity in eosinophils. Adhesiveness of VLA-4 ($\alpha $4$\beta $1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 ($\alpha $M$\beta $2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn$^{2+}$-inducible $\beta $1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a $\beta $1 and a $\beta $2 integrin expressed on the same leukocyte. |
---|---|
AbstractList | The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of beta 1 and beta 2 integrin avidity in eosinophils. Adhesiveness of VLA-4 (alpha 4 beta 1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 (alpha M beta 2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn2+-inducible beta 1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a beta 1 and a beta 2 integrin expressed on the same leukocyte. The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of beta 1 and beta 2 integrin avidity in eosinophils. Adhesiveness of VLA-4 ( alpha 4 beta 1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 ( alpha M beta 2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn super(2+)-inducible beta 1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a beta 1 and a beta 2 integrin expressed on the same leukocyte. The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a, induce activation, degranulation, chemotaxis, and transendothelial migration of eosinophils. Adhesion assays on purified ligands showed differential regulation of $\beta $1 and $\beta $2 integrin avidity in eosinophils. Adhesiveness of VLA-4 ($\alpha $4$\beta $1, CD29/CD49d) for vascular cell adhesion molecule 1 or fibronectin was rapidly increased but subsequently reduced by RANTES, MCP-3, or C5a. The deactivation of VLA-4 lead to cell detachment, whereas phorbol 12-myristate 13-acetate induced sustained activation of VLA-4. In contrast, chemoattractants stimulated a prolonged increase in the adhesiveness of Mac-1 ($\alpha $M$\beta $2, CD11b/CD18) for intercellular adhesion molecule 1. Inhibition by pertussis toxin confirmed signaling via G protein-coupled receptors. Chemoattractants induced transient, while phorbol 12-myristate 13-acetate induced sustained actin polymerization. Disruption of actin filaments by cytochalasins inhibited increases in avidity of VLA-4 but not of Mac-1. Chemoattractants did not upregulate a Mn$^{2+}$-inducible $\beta $1 neoepitope defined by the mAb 9EG7, but induced prolonged expression of a Mac-1 activation epitope recognized by the mAb CBRM1/5. This mAb inhibited chemoattractant-stimulated adhesion of eosinophils to intercellular adhesion molecule 1. Thus, regulation of VLA-4 was dependent on the actin cytoskeleton, whereas conformational changes appeared to be crucial for activation of Mac-1. To our knowledge, this is the first demonstration that physiological agonists, such as chemoattractants, can differentially regulate the avidity of a $\beta $1 and a $\beta $2 integrin expressed on the same leukocyte. |
Author | Weber, Christian Kitayama, Joji Springer, Timothy A. |
AuthorAffiliation | Center for Blood Research, Harvard Medical School, Boston, MA 02115, USA |
AuthorAffiliation_xml | – name: Center for Blood Research, Harvard Medical School, Boston, MA 02115, USA |
Author_xml | – sequence: 1 givenname: Christian surname: Weber fullname: Weber, Christian – sequence: 2 givenname: Joji surname: Kitayama fullname: Kitayama, Joji – sequence: 3 givenname: Timothy A. surname: Springer fullname: Springer, Timothy A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8855287$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1rGzEQxUVJSZ2091Io1SGEXNbVx65WC70EN0kDgUBpbwUhrSRbYS05kjbU_3212DXppTkNw_u9YR7vBBz54A0A7zGaY9TSzxsv07yjczLtHe1egVmZuGJ1h47ADCHSVrwm9RtwktIDQqhrODoGx5w3DeHtDNivzloTjc9ODvC7WY6DzC54GCw8-6VMlvAMQ-n1YSPw1mezjM7DyyenXd5CtYWLlVkHmXOUfZY-J1jkq5CcD5uVG9Jb8NrKIZl3-3kKfl5f_Vh8q-7ub24Xl3dVX3d1riRDppbSatSQvrEMYa5LHosURdgqxXrTWkKKqHCLW62ssrU0THPNlNYNPQVfdnc3o1ob3ZdcUQ5iE91axq0I0ol_Fe9WYhmeBOWEkWI_39tjeBxNymLtUm-GQXoTxiRaXmPWEfYiiBveYEpwAdEO7GNIKRp7-AUjMVUopgpFRwWZ9lJhsXx8nuFg2HdW9Iu9Pjn_qs8uCDsOQza_c0E__R8txIcd8ZByiAekRoRh-geXdLzH |
CitedBy_id | crossref_primary_10_1016_S1074_7613_00_00074_1 crossref_primary_10_1186_s13075_015_0664_8 crossref_primary_10_4049_jimmunol_160_11_5622 crossref_primary_10_1007_s00441_004_0925_3 crossref_primary_10_1091_mbc_12_7_2137 crossref_primary_10_1182_blood_V96_2_506_014k41_506_513 crossref_primary_10_1189_jlb_0104054 crossref_primary_10_1007_s11882_004_0061_x crossref_primary_10_1091_mbc_10_4_861 crossref_primary_10_1159_000053588 crossref_primary_10_1016_S0022_1759_00_00192_7 crossref_primary_10_1165_rcmb_2004_0099OC crossref_primary_10_1046_j_1365_2141_1999_01714_x crossref_primary_10_1096_fj_04_3085fje crossref_primary_10_4049_jimmunol_160_10_4889 crossref_primary_10_1002_1521_4141_200204_32_4_1069__AID_IMMU1069_3_0_CO_2_E crossref_primary_10_1046_j_1365_2567_1999_00766_x crossref_primary_10_1084_jem_193_10_1149 crossref_primary_10_1067_mai_2000_110797 crossref_primary_10_1074_jbc_M907390199 crossref_primary_10_1182_blood_V95_2_592 crossref_primary_10_1182_blood_V96_2_506 crossref_primary_10_1074_jbc_M212538200 crossref_primary_10_1002_art_30582 crossref_primary_10_1189_jlb_0707478 crossref_primary_10_1074_jbc_M210472200 crossref_primary_10_1111_j_1365_2567_2008_02906_x crossref_primary_10_1165_rcmb_2006_0027OC crossref_primary_10_1016_S1081_1206_10_61311_7 crossref_primary_10_1159_000053592 crossref_primary_10_1074_jbc_273_17_10556 crossref_primary_10_1189_jlb_0607344 crossref_primary_10_1155_2015_301716 crossref_primary_10_4049_jimmunol_161_2_971 crossref_primary_10_1189_jlb_1105643 crossref_primary_10_4049_jimmunol_169_5_2670 crossref_primary_10_1034_j_1600_065X_2002_18604_x crossref_primary_10_1242_jcs_02632 crossref_primary_10_1189_jlb_71_5_798 crossref_primary_10_1189_jlb_71_3_520 crossref_primary_10_1124_mol_105_018374 crossref_primary_10_1165_ajrcmb_20_6_3531 crossref_primary_10_1074_jbc_M206208200 crossref_primary_10_1161_01_ATV_0000200226_53994_09 crossref_primary_10_4049_jimmunol_164_6_3292 crossref_primary_10_1189_jlb_72_5_1046 crossref_primary_10_1016_S0091_6749_97_70027_7 crossref_primary_10_4049_jimmunol_168_3_1380 crossref_primary_10_1096_fj_02_0739rev crossref_primary_10_1006_smim_2001_0346 crossref_primary_10_1006_smim_2001_0345 crossref_primary_10_1016_S0955_0674_02_00371_X crossref_primary_10_1182_blood_2007_05_093294 crossref_primary_10_1189_jlb_0605318 crossref_primary_10_1038_sj_mn_7800195 crossref_primary_10_1016_S0166_2236_98_01390_3 crossref_primary_10_1046_j_1365_2567_2002_01486_x crossref_primary_10_1111_j_1365_2567_2005_02214_x crossref_primary_10_1016_j_intimp_2007_07_006 crossref_primary_10_1111_j_1750_3639_2007_00067_x crossref_primary_10_1016_j_it_2003_08_001 crossref_primary_10_1189_jlb_68_5_679 crossref_primary_10_1007_s11882_002_0005_2 crossref_primary_10_1038_ni755 crossref_primary_10_1016_S0022_1759_99_00052_6 crossref_primary_10_1002__SICI_1521_4141_199807_28_07_2245__AID_IMMU2245_3_0_CO_2_V crossref_primary_10_4049_jimmunol_166_1_588 crossref_primary_10_1002_1521_4141_200204_32_4_1129__AID_IMMU1129_3_0_CO_2_G crossref_primary_10_1080_15419060390262507 crossref_primary_10_1152_ajpheart_00349_2002 crossref_primary_10_1165_rcmb_2006_0391OC crossref_primary_10_1111_cea_12292 crossref_primary_10_1074_jbc_M402944200 crossref_primary_10_1083_jcb_142_2_595 crossref_primary_10_1006_cimm_1999_1596 crossref_primary_10_3390_cancers16030559 crossref_primary_10_1038_sj_bjp_0701243 crossref_primary_10_1083_jcb_137_6_1433 crossref_primary_10_1093_rheumatology_kei207 crossref_primary_10_3390_biomedicines12010124 crossref_primary_10_1091_mbc_12_10_3074 crossref_primary_10_4049_jimmunol_161_12_6825 crossref_primary_10_1016_S0955_0674_97_80127_5 crossref_primary_10_1159_000059412 crossref_primary_10_1006_pupt_2000_0250 crossref_primary_10_1111_j_1600_065X_2012_01127_x crossref_primary_10_1159_000059414 crossref_primary_10_4049_jimmunol_1401889 crossref_primary_10_1016_S0955_0674_00_00253_2 crossref_primary_10_1016_S0162_3109_99_00178_2 crossref_primary_10_1056_NEJM199805283382206 crossref_primary_10_1074_jbc_M600943200 crossref_primary_10_1046_j_1365_2567_2000_00123_x crossref_primary_10_4049_jimmunol_163_6_3423 crossref_primary_10_4049_jimmunol_164_2_746 crossref_primary_10_4161_cam_4_1_10976 crossref_primary_10_1016_j_iac_2007_07_004 crossref_primary_10_1046_j_1440_1711_2001_01004_x crossref_primary_10_1186_s12967_021_02822_5 crossref_primary_10_4049_jimmunol_160_7_3569 crossref_primary_10_1016_S0091_6749_99_70281_2 crossref_primary_10_4049_jimmunol_165_5_2748 crossref_primary_10_4049_jimmunol_167_11_6171 crossref_primary_10_1093_intimm_11_1_1 crossref_primary_10_1165_ajrcmb_19_3_3179 crossref_primary_10_1590_S0074_02761997000800021 crossref_primary_10_4049_jimmunol_164_8_4313 crossref_primary_10_4049_jimmunol_162_2_1084 crossref_primary_10_1016_S0091_6749_97_70158_1 crossref_primary_10_1016_j_cyto_2010_02_016 crossref_primary_10_4049_jimmunol_161_11_5978 crossref_primary_10_4049_jimmunol_1900914 crossref_primary_10_1084_jem_186_2_313 crossref_primary_10_4049_jimmunol_1901134 crossref_primary_10_1159_000053844 crossref_primary_10_1152_ajplung_00437_2001 crossref_primary_10_1097_00003246_200004001_00003 crossref_primary_10_4049_jimmunol_175_9_6092 crossref_primary_10_1067_mai_2000_110813 crossref_primary_10_1006_clim_1999_4829 crossref_primary_10_1016_S0006_3495_04_74196_X crossref_primary_10_1046_j_1365_2222_2000_00779_x crossref_primary_10_1007_s10719_008_9215_8 crossref_primary_10_1074_jbc_273_24_15271 crossref_primary_10_1111_j_1365_2222_2007_00117_x crossref_primary_10_1067_mai_2003_1515 crossref_primary_10_1007_s00223_006_0115_2 crossref_primary_10_1016_S0301_472X_00_00668_8 crossref_primary_10_1067_mai_2001_118600 crossref_primary_10_1016_S0955_0674_97_80117_2 crossref_primary_10_1046_j_1365_2249_2000_01249_x crossref_primary_10_1002__SICI_1521_4141_199911_29_11_3571__AID_IMMU3571_3_0_CO_2_V crossref_primary_10_1080_10408369991239277 crossref_primary_10_4049_jimmunol_166_5_3515 crossref_primary_10_1074_jbc_M700341200 crossref_primary_10_1080_10739680600776062 crossref_primary_10_1007_s00005_013_0221_6 crossref_primary_10_1084_jem_192_4_495 crossref_primary_10_1111_cen3_12229 crossref_primary_10_1182_blood_V95_5_1804_005k11_1804_1809 crossref_primary_10_1165_rcmb_2008_0047OC crossref_primary_10_4049_jimmunol_163_3_1611 crossref_primary_10_4049_jimmunol_166_9_5755 crossref_primary_10_1074_jbc_M103194200 crossref_primary_10_4049_jimmunol_175_8_5341 crossref_primary_10_1189_jlb_0502264 crossref_primary_10_1002_1521_4141_200108_31_8_2458__AID_IMMU2458_3_0_CO_2_L |
ContentType | Journal Article |
Copyright | Copyright 1996 National Academy of Sciences |
Copyright_xml | – notice: Copyright 1996 National Academy of Sciences |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 7X8 5PM |
DOI | 10.1073/pnas.93.20.10939 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 10944 |
ExternalDocumentID | 10_1073_pnas_93_20_10939 8855287 93_20_10939 40261 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA31799 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 79B 85S AACGO AAFWJ AANCE ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACIWK ACKIV ACNCT ACPRK ADULT ADZLD AENEX AEUPB AEXZC AFDAS AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM ASUFR AS~ CS3 D0L DCCCD DIK DNJUQ DOOOF DU5 DWIUU E3Z EBS EJD F20 F5P FRP GX1 HGD HH5 HQ3 HTVGU HYE JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KQ8 L7B LU7 MVM N9A NEJ NHB N~3 O9- OK1 P-O PNE PQQKQ R.V RHF RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH VQA W8F WH7 WHG WOQ WOW X7M XFK XSW Y6R YKV YSK ZA5 ZCA ZCG ~02 ~KM - 02 08R 0R 1AW 55 AAPBV ABFLS ABPTK ADACO AJYGW AS DZ GJ KM OHM PQEST X XHC ADACV CGR CUY CVF ECM EIF H13 IPSME NPM 692 6TJ AAYJJ AAYXX BKOMP CITATION YBH 7T5 H94 7X8 5PM |
ID | FETCH-LOGICAL-c494t-a60e4aafd052c5f6018d109f0b301fbb6ce7f2252cb1717dbfbf4ae6d8d6bdd53 |
IEDL.DBID | RPM |
ISSN | 0027-8424 |
IngestDate | Tue Sep 17 21:17:24 EDT 2024 Sat Oct 26 00:21:40 EDT 2024 Fri Oct 25 21:54:31 EDT 2024 Fri Aug 23 03:33:49 EDT 2024 Sat Sep 28 08:34:39 EDT 2024 Wed Nov 11 00:29:44 EST 2020 Wed May 29 08:07:22 EDT 2019 Fri Feb 02 07:05:47 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 20 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c494t-a60e4aafd052c5f6018d109f0b301fbb6ce7f2252cb1717dbfbf4ae6d8d6bdd53 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://europepmc.org/articles/pmc38262?pdf=render |
PMID | 8855287 |
PQID | 15851321 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_38262 proquest_miscellaneous_15851321 crossref_primary_10_1073_pnas_93_20_10939 jstor_primary_40261 pnas_primary_93_20_10939_fulltext proquest_miscellaneous_78416926 pubmed_primary_8855287 pnas_primary_93_20_10939 |
ProviderPackageCode | RNA PNE |
PublicationCentury | 1900 |
PublicationDate | 19961001 1996-10-01 1996-Oct-01 1996-10-00 |
PublicationDateYYYYMMDD | 1996-10-01 |
PublicationDate_xml | – month: 10 year: 1996 text: 19961001 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 1996 |
Publisher | National Academy of Sciences of the United States of America National Acad Sciences |
Publisher_xml | – name: National Academy of Sciences of the United States of America – name: National Acad Sciences |
SSID | ssj0009580 |
Score | 1.9934286 |
Snippet | The CC chemokines regulated on activation normal T expressed and secreted (RANTES) and monocyte chemotactic protein 3 (MCP-3), and the anaphylatoxin C5a,... |
SourceID | pubmedcentral proquest crossref pubmed pnas jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 10939 |
SubjectTerms | Actins CD18 Antigens - physiology Cell Adhesion Chemokine CCL5 - metabolism Chemokine CCL7 Chemotactic factors Chemotactic Factors - physiology Chemotaxis, Leukocyte Complement C5a - metabolism Cytokines Endothelium Eosinophils Eosinophils - physiology Epitopes Fibronectins - metabolism Fibrosis Humans Integrin alpha4beta1 Integrin beta1 - physiology Integrins Integrins - physiology Isotypes Ligands Macrophage-1 Antigen - physiology Monocyte Chemoattractant Proteins - metabolism Physiological regulation Receptors, Lymphocyte Homing - physiology Vascular Cell Adhesion Molecule-1 - metabolism |
Title | Differential Regulation of $\beta $1 and $\beta $2 Integrin Avidity by Chemoattractants in Eosinophils |
URI | https://www.jstor.org/stable/40261 http://www.pnas.org/content/93/20/10939.abstract https://www.ncbi.nlm.nih.gov/pubmed/8855287 https://search.proquest.com/docview/15851321 https://search.proquest.com/docview/78416926 https://pubmed.ncbi.nlm.nih.gov/PMC38262 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6aQCGX0qQNcZqHCj00B-_asvw6lrQhSUnpoYHcXD2JYVdeYufQf9-RLC_Z0lxyM9IIm3lYM8ynTwCfZCoxKUhUjMlwEjOd6rhivIx5omWZas2kpxS6-VFc3rLru_wunOPuA6zSStHO7GI5s-29x1aulnI-4cTmP2_OM8yJ6XwLttA9pwJ9zbNbjadOKP58GWWhM4mOPF9Z3s_qDGtCz6FU78Drqspz6tB0T_akEZbouE5R_n9557_wySf70cVbeBMSSfJl_OBdeKXtHuyGUO3J58AnffYOfn8Nl6BgMC_Iw3j5PJqDdIYIPXCSEm7V-EjJyB_RWuLA7piiE_GHoGGXHR8Gd6LK4WZQiOiub223um8X_Xu4vfj26_wyDhcrxJLVbIh5kWjGuVFJTmVusCarFKrEJALD3QhRSF0aDHQqRYrlnhJGGMZ1oSpVCKXybB-2bWf1ARDN0tJkWJ4LzRlNlKgcnwsTBeWsNiyL4GxSbbMa-TMa3_cus8YpuKmzhvo-eFZHsOd1vxZkrkCM4MALToMbCz4-N9WYgJ2J4HSyYIOR49oh3OrusW9S1xHNaPq8hO_J1rSIYH-0-PpNwXEiyDdcYT3vSLs3Z9CXPXm3993DF677ADseNe7BhEewPTw86mNMigZxguXA1fcTHwx_AQD4Dqw |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEaKXihaqBgo1Egd6yG7iOK8jKlQLdCsOrdRb8FONtOusmvTAv2fseFddRC_cInusRPOIZzSfPwN8lKnEpCBRMSbDScx0quOK8TLmiZZlqjWTnlJoflnMrtn3m_wmnOPuA6zSStFO7GI5se2tx1aulnK6xolNf87PMsyJ6fQpPMNoTdi6RN8w7VbjuROKv19GWehNoitPV5b3kzrDqtCzKNW78Lyq8pw6PN2DXWkEJjq2U5T_V-b5N4DywY50_hL2QipJPo-fvA9PtD2A_RCsPfkUGKVPX8GvL-EaFAznBbkbr59Hg5DOEKEHTlLCrRofKRkZJFpLHNwdk3QifhM07bLjw-DOVDnkDAoR3fWt7Va37aJ_DdfnX6_OZnG4WiGWrGZDzItEM86NSnIqc4NVWaVQJSYRGPBGiELq0mCoUylSLPiUMMIwrgtVqUIolWeHsGM7q4-AaJaWJsMCXWjOaKJE5RhdmCgoZ7VhWQSna9U2q5FBo_Gd7zJrnIKbOmuo74RndQQHXvcbQeZKxAiOvOB6cGvBh8emGhPQMxGcrC3YYOy4hgi3urvvm9T1RDOaPi7hu7I1LSI4HC2-eVNwnAjyLVfYzDva7u0Z9GZP3-29981_rjuBF7Or-UVz8e3yx1vY9RhyDy08hp3h7l6_wxRpEO99SPwB_aoRCQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEagXRAtVw6tG4kAP2SSO8zqillV5tOqBSr0FP9VIu07UpAf-PWMnWXURvXCL4rESzSOeyXz-DPBRJhKTgliFmAzHIdOJDkvGi5DHWhaJ1kx6SqHzi_zsin27zq6nXxf9BKu0UjQLu1ovbHPjsZXdWkYzTiy6PD9JMSemUadM9BieYMTG-Vymb9h2y3HvCcVPMKNs6k-iO0ed5f2iSrEy9ExK1S48Lcssow5Td29lGsGJjvEU5f-Vff4Nory3Ki1fwPMpnSSfx9feg0fa7sPeFLA9-TSxSh-_hF-n01EoGNIrcjseQY9GIa0hQg-cJIRbNV5SMrJINJY4yDsm6kT8JmjedcuHwe2rcugZFCK67RvbdjfNqn8FV8svP0_Owul4hVCyig0hz2PNODcqzqjMDFZmpUKVmFhg0BshcqkLg-FOpUiw6FPCCMO4zlWpcqFUlh7Ajm2tPgSiWVKYFIt0oTmjsRKlY3VhIqecVYalARzPqq27kUWj9t3vIq2dgusqranvhqdVAPte9xtB5srEAA694Hxza8KHh4ZqMyFoAjiaLVhj_LimCLe6vevrxPVFU5o8LOE7sxXNAzgYLb550uQ4AWRbrrAZd9Td2yPo0Z7C23vw6_-cdwTPLk-X9Y-vF9_fwK6HkXt04VvYGW7v9DvMkgbx3kfEH-AAEhw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+regulation+of+beta+1+and+beta+2+integrin+avidity+by+chemoattractants+in+eosinophils&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Weber%2C+C&rft.au=Kitayama%2C+J&rft.au=Springer%2C+T+A&rft.date=1996-10-01&rft.issn=0027-8424&rft.volume=93&rft.issue=20&rft.spage=10939&rft_id=info:doi/10.1073%2Fpnas.93.20.10939&rft_id=info%3Apmid%2F8855287&rft.externalDocID=8855287 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F93%2F20.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F93%2F20.cover.gif |